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AktAcidic tumor microenvironment and Wnt/β-catenin pathway activation have been recognized as two crucial
events associated with the initiation and progression of cancer. The aim of this study was to clarify the mo-
lecular mechanisms underlying the anti-proliferative effects of atrial natriuretic peptide (ANP) as well as to
investigate the relationship between the cellular pH and the Wnt/β-catenin signaling in cancer cells.To pur-
sue our aims, we conducted investigations in DHD/K12/Trb rat colon adenocarcinoma cells. Intracellular pH
was measured by Confocal Laser Scanning Microscopy (CLSM) using the lysosensor Green DND-189 probe.
Expression of crucial molecules in the Wnt/β-catenin signaling pathway was analyzed by CLSM, western
blot, and real time PCR. Measurements of activation (phosphorylation state) of Akt, ERK1/2, and p38MAPKi-
nase were performed by Reverse-Phase Protein Microarray Analysis (RPMA).We showed that ANP triggered a
NHE-1-mediated increase of the intracellular acidity, inhibiting the Wnt/β-catenin signaling simultaneously.
Moreover, we observed that the Wnt1a, a Wnt signaling activator, affected the intracellular pH in an opposite
fashion. Results from the comparative analysis of ANP and EIPA (a NHE-1 speciﬁc inhibitor) showed that
these two molecules affect both the intracellular acidiﬁcation and the Wnt/β-catenin signaling cascade. Spe-
ciﬁcally, ANP acts on the upstream of the cascade, through a Frizzled-mediated activation, while EIPA does on
the downstream.We show for the ﬁrst time that the Akt activity might be a relevant molecular event linking
the NHE-1-regulated intracellular pH and the Wnt/β-catenin signaling. This provides evidence for a cross-
talk between the intracellular alkalinization and the Wnt signaling in tumor cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
In solid tumors, intracellular alkalinization and microenvironmen-
tal acidiﬁcation play crucial roles in cell proliferation [1], invasion and
metastatization [2], and drug resistance and apoptosis [3]. Speciﬁcal-
ly, evidence showed that cytoplasmic alkalinization is an early event
in tumorigenic transformation that is driven by a stimulation of the
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l rights reserved.system that regulates pH homeostasis in cancer extracellular micro-
environment, that is more acidic than in normal conditions [4]. Fur-
thermore, numerous studies have demonstrated the key role of
deregulation or constitutive activation of the Wnt signaling pathway
in the initiation and progression of different forms of human cancer.
Hence, several molecular components in the Wnt signaling pathway
have been proposed as novel targets for cancer therapy [5,6].
In tumor cells, the existence of cross-talk between the pH regulator-
dependent intracellular alkalinization and the Wnt signaling cascade
has never been explored. Cellular pH regulators, such as Proton
Pumps (PP) and Sodium/Proton Exchangers (NHE) have been proposed
as molecular targets for cancer chemotherapy [7,8]. However, it has
never been investigated if perturbations of tumor microenvironment
using PP or NHE inhibitors are able to affect the Wnt pathway.
Atrial natriuretic peptide (ANP) belongs to a family of cardiac and
vascular-derived peptide hormones that plays a crucial role in cardio-
vascular homeostasis through blood pressure and volume regulation
[9,10]. ANP is synthesized as an inactive precursor (pro-ANP) that is se-
creted from cardiomyocytes and proteolytically cleaved by a
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ture active peptide [11,12]. The extracellular region of Corin, that con-
tains the structural domains essential for pro-ANP processing [11],
includes two Frizzled-like cysteine-rich domains (Frizzled1 and Friz-
zled2), which are transmembrane receptors for the Wnt signaling [13].
ANP has been also shown to inhibit tumor growth in vitro and in
vivo studies [14–19]. Particularly, ANP exerts its anti-tumor effect
by inhibiting DNA synthesis without inducing apoptosis [14]. The
anti-proliferative efﬁcacy of ANP has been extensively demonstrated
in various forms of human cancer, including pancreatic adenocarcino-
ma, breast, prostate, colon, renal, ovarian, small cell and squamous
cell lung cancers, as well as in diverse types of tumors [21]. Therefore,
ANP and other natriuretic peptides (i.e. vessel dilator, long-acting na-
triuretic, and kaliuretic peptides) have been proposed as potential
candidates for anti-cancer therapy [20].
Although themolecular mechanism underlying the anti-proliferative
effect of ANP is not yet understood, manymodalities of action have been
proposed. For example, a direct interaction of the peptide with growth-
promoting hormones in the nucleus has beenhypothesized given the ob-
served localization of ANP in the nuclear compartment of humanpancre-
atic adenocarcinoma cells [22]. Other works have proposed that the ANP
anti-cancer effectmight be due to its involvement in the inhibition of ex-
tracellular signal-regulated kinase (ERK) 1/2 [23] and in the inhibition of
mitogens to activate Ras [24]. Furthermore, a potential interaction be-
tween ANP and its speciﬁc receptors NPR-A, NPR-B and NPR-C, which
are expressed at different levels on tumor cells [14–19] has also been
proposed [21,25]. Moreover, it has been reported that ANP is able to
modify the intracellular pH by inhibiting or stimulating the Sodium/Pro-
ton exchanger isoform 1 (NHE-1) depending on the cell type [26,27].
Speciﬁcally, in HepG2 hepatoblastoma cells, ANPwas found to induce in-
tracellular acidiﬁcation by decreasing NHE-1 expression and activity
[28]. Thus, the NHE-1-dependent intracellular acidiﬁcation induced by
ANP in tumor cells might also mediate its anti-proliferative activity. Ad-
ditionally, the presence of the Frizzled-likeWnt receptor in the extracel-
lular region of Corin supports the plausibility that ANP affects directly or
indirectly the Wnt signaling cascade.
In the present study, we aimed to investigate i) the anti-proliferative
effect of ANP correlated to the induction of aNHE-1-dependent intracel-
lular acidiﬁcation in tumor cells; ii) the possibility that ANP treatment
inﬂuences theWnt/β-catenin signaling pathway; and iii) the likelihood
of cross-talk between the cellular pH and the Wnt signaling pathway.
We mainly analyzed the effect of ANP on DHD/K12/Trb cell line,
originally established from 1,2-dimethylhydrazine-induced colon ade-
nocarcinoma in syngeneic BDIX rats. These cells displaymany of the fea-
tures of human epithelial cells constituting the colorectal cancer tissue,
including both the expression of human tumor-associated antigens
[29,30] and the constitutive activation of the Wnt/β-catenin pathway,
as demonstrated by nuclear β-catenin distribution and low expression
of E-cadherin at cell membrane (Supplementary Fig. 1).
2. Materials and methods
2.1. Rat and human tumor cell lines
DHD/K12/Trb cell linewas obtained from the European Collection of
Cell Culture (ECACC, Salisbury, UK). The human colorectal cancer cell
line SW620 was obtained from the American Type Culture Collection
(ATCC, Manassas, VA, USA). The human breast cancer cell line MDA-
MB-231 was obtained from Interlab Cell Line Collection (ICLC, Genoa,
Italy). All cell lines were authenticated by the purchaser cell bank.
Upon arrival to our laboratory, all cell lines were expanded for about
2 weeks, aliquoted, and stored in liquid nitrogen. For each experiment,
an aliquot of each cell line was resuscitated and thenmaintained in cul-
ture for a maximum of 2 months before usage. Cell lines were grown as
monolayer in Dulbecco's Minimal Essential Medium (DMEM), for
SW620 and MDA-MB231 cells, and in DMEM plus HAM's F10 (1:1),for DHD/K12/Trb cells. Culture media were supplemented with 10%
heat-inactivated Fetal Bovine Serum (FBS), L-glutamine (2 mM), peni-
cillin (100 IU/ml) and streptomycin (100 μg/ml) and cell cultures
were maintained at 37 °C, in a humidiﬁed atmosphere of 5% CO2. Cells
were passaged after being detached from culture ﬂaskswith 0.05% tryp-
sin and 0.002% EDTA solution. All media and supplements for cell cul-
tures were obtained from Hyclone (Logan, UT, USA).
2.2. In vitro treatments and antibodies used
Exponentially growing cells were seeded at a density of 6×104/cm2
and were maintained in culture for 24 h prior to treatments. Cells
were treatedwith 1 μMANP (PeptaNova, Sandhausen, Germany ), a con-
centration selected as the lowest effective dose in a preliminary dose–re-
sponse experiments, for a period of 1 h to 24 h. Formicroscopic analyses,
cellswere grownon cover-slips. For the competition experiments regard-
ing the Frizzled receptor binding, DHD/K12/Trb cells were either (a) pre-
incubatedwith 100 μg/mlWnt1a (Abcam, Cambridge,MA,USA) 1 hprior
to the addition of 1 μM ANP or (b) pre-incubated with 1 μMANP or 1 μM
5-(Nethyl-N-isopropyl) amiloride (EIPA; Sigma-Aldrich, St. Louis, MO,
USA) 1 h prior to the addition of 100 μg/ml Wnt1a. Following 5 h later,
β-cateninin immunoﬂuorescent staining and evaluation of Ki67positivity
were performed. Details on the antibodies and dilutions used in this
study are given in Supplementary Table 1.
2.3. Cell proliferation analyses
Cell proliferation was assessed by confocal microscopy and by
ﬂow cytometry, as follows:
i) Mitotic index (MI) evaluation, carried out on cells ﬁxed with
4% paraformaldehyde and stained with 2 μg/ml propidium io-
dide (PI) plus 0.1 mg/ml RNase (Sigma-Aldrich) for nuclei vi-
sualization. Quantitative assessment was done in a blinded
fashion under a LEICA TCS SP5 Confocal Laser Scanning Micros-
copy (CLSM, Leica Instruments, Mannheim, Germany). A mini-
mum of 500 cells/sample were counted and results were given
as percentage of cells in mitosis.
ii) Immunoﬂuorescent staining of Ki67, performed using the spe-
ciﬁc rabbit monoclonal antibody (Supplementary Table 1),
detected with the Alexa Fluor 488-conjugated anti-rabbit IgG
(Molecular Probes, Eugene, OR, USA). The percentage of cells
exhibiting Ki67 positivity was obtained analyzing in a blinded
fashion a minimum of 500 cells/sample by CLSM.
iii) Bromodeoxyuridine (BrdU) incorporation method using the
FITC BrdU Flow Kit (BD Pharmingen, San Jose, CA, USA) accord-
ing to manufacturer's instructions. Brieﬂy, cells were incubated
with 10 μg/ml BrdU for 30 min, ﬁxed and permeabilized prior
to the treatment with DNAse (300 μg/ml) for 1 h to expose
the incorporated BrdU. Cells were then incubated with FITC-
conjugated anti-BrdU antibody (BD Pharmingen) for 20 min
and counterstained with 7-Aminoactinomycin D (7-AAD) to
determine the total DNA content. FITC intensity and total
DNA content was measured using the FACS-Scan ﬂow cyt-
ometer (Becton Dickinson, Franklin Lakes, NJ, USA).
2.4. Analysis of the intracellular pH
Intracellular pH changes were evaluated using the acidotropic
probe LysoSensor Green DND-189 (Molecular Probes), as previously
described [31]. This probe freely passes through cell membranes
and typically concentrates in acidic organelles. It does not give the
exact value of intracellular pH/[H+] variation but exhibits a pH-
dependent increase or decrease in ﬂuorescence intensity upon intra-
cellular acidiﬁcation or alkalinization, respectively. Cells were loaded
1 h at 37 °C with 1 μM LysoSensor dye, added into the culture
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lyzed by CLSM. The pH variations were measured on living cells and
monitored during the ﬁrst 240 s of treatment. The changes in ﬂuores-
cence intensity of LysoSensor probe were recorded in Live Data Mode
acquisition. The excitation/emission wavelengths employed were
488 nm/510 nm. The quantitative analyses were performed within
regions of interest (ROIs — LysoSensor stained cytosol and acidic
compartments) using the Leica application suite for advanced ﬂuores-
cence (LasAF) software (Leica Instruments). In each ﬁeld examined,
at least 20 equivalent-sized ROIs were identiﬁed, monitored, and an-
alyzed during the time course experiments. For each sample, the ﬁnal
curve was obtained as mean ﬂuorescence intensity value of all ROIs
examined from three different experiments. The effect of ANP was
compared to that of EIPA, used as positive control of NHE-1-
mediated intracellular acidiﬁcation, and of Wnt1a.
2.5. Immunocytochemical analysis
Immunocytochemical analysis was carried out on cells ﬁxed with
4% paraformaldehyde (Sigma-Aldrich) and permeabilized with 0.2%
Triton X-100 (Sigma-Aldrich). Immunoﬂuorescence staining was per-
formed using the primary antibodies against β-catenin, E-cadherin,
adenomatous polyposis coli (APC), glycogen synthase kinase 3β
(GSK-3β), ANP and Frizzled2, detailed in Supplementary Table 1.
The speciﬁcity of each antibody has been preliminary assessed by
Western blot analysis, taking into account the production of a single
band matched to the proper molecular weight. Primary antibodies
were detected with Alexa Fluor 488-conjugated anti-mouse or anti-
rabbit IgG (Molecular Probes). Samples were observed with a LEICA
TCS SP5 confocal microscope. For the analysis of samples double-
stained for β-catenin/APC, β-catenin/GSK-3β and ANP/Frizzled2,
the merged images, and the intracellular distribution of the colocali-
zation areas, and the measurement of colocalization rate ( CR ¼
ColocalizationArea
AreaForeground
, where Area Foreground=Area Image-Area Back-
ground) were obtained using the LasAF software (Leica Instruments);
the mean CRs were calculated analyzing a minimum of 10 ﬁelds/sam-
ple, in a blind fashion.
2.6. Western blot (WB) analysis
For total cell extracts, cells were lysed using a 50 mM Tris–HCl
buffer with pH of 8.0. Speciﬁcally, the buffer solution contained
150 mM of NaCl, 1% of NP-40, 10% of glycerol, 0.1 mM of EGTA,
0.5 mM of EDTA, 50 mM of NaF, 1 mM of Na3OV4 phosphatase inhib-
itors, and a protease inhibitor cocktail (Sigma-Aldrich). Preparation of
membrane and cytosol/nuclear extracts was performed as described
by Maier et al. [32]. Brieﬂy, cells were sonicated in buffer [10 mM
Tris/HCl, pH 7.2, 1 mM EDTA, 1 mM mercaptoethanol, 5% glycine,
1 mM PMSF (phenylmethylsulfonylﬂuoride), and 5 mM DTT (dithio-
threitol)] and then centrifuged at 14,000 rpm for 10 min. The super-
natant containing cytoplasmatic and nuclear proteins was used for
the analysis of soluble extracts. The remaining pellet, mostlyTable 1
Sequences of primer pairs used for quantitative PCR measurements.
Name Accession number Fo
β-actin NM0311442 T
APC NM0124991 T
GSK NM0320801 G
c-Myc NM0126032 A
Cyclin-D1 NM1719924 G
E-cadherin NM0313341 C
The name of the genes, their GENBANK accession number and 5′ to 3′ nucleotide sequence
polyposis coli; GSK: glycogen synthase kinase.containing cell membrane constituents, was washed with PBS, solubi-
lized in running buffer with mercaptoethanol and sodium-
dodecylsulfate (SDS) and used for the analysis of the membrane ex-
tracts. 40μg of each cell extract was subjected to 12% of SDS-PAGE
and then electroblotted onto a PVDF membrane (Immobilon-P, Milli-
pore, Billerica, MA, USA). Membranes were incubated with the anti-
bodies against β-catenin, E-cadherin, pβ-cateninSer33/Ser37/Thr41,
pGSK-3βSer9, and β-actin (loading control), detailed in Supplementa-
ry Table 1, revealed with peroxidase-conjugated secondary anti-
bodies (BioRad, Richmond, CA, USA). Western blots were developed
using the ECL Detection System (Amersham, Uppsala, Sweden). Den-
sitometric analysis was performed using the ImageJ processing pro-
gram [http://rsbweb.nih.gov/ij/]. Values were normalized to β-actin
and were reported as uncalibrated Optical Density (OD). Data were
presented as the mean±S.D.
2.7. Quantitative reverse transcription polymerase chain reaction
(QPCR)
Transcription levels of APC, GSK, c-Myc, Cyclin-D,1 and E-cadherin
genes were evaluated by QPCR in untreated controls and in cells trea-
ted with1 μM ANP or 1 μM EIPA, at times ranging from 1 h to 10 h.
Total RNA was extracted using TRIzol™ Reagent (Invitrogen, Carls-
bad, CA, USA). The purity, integrity, and yield of RNA was monitored
by micro-capillary electrophoresis (Bioanalyzer 2100, Agilent Tech-
nologies, Santa Clara, CA, USA) using the RNA 6000 LabChip kit. 1 μg
of total RNA was treated with DNAse I Ampliﬁcation Grade (Invitro-
gen) and was reverse-transcribed using the SuperScript™ III (Invitro-
gen). Quantitative PCR was performed in ABI PRISM 7000 light cycler
(Applied Biosystems, Carlsbad, CA, USA) using SYBR Greener qPCR
SuperMix for ABI Prism (Invitrogen). All primers were optimized for
real-time RT-PCR ampliﬁcation by checking i) the generation of a sin-
gle amplicon in a melting curve assay and ii) the efﬁciency in a stan-
dard curve ampliﬁcation (>98% for each couple of primers).
Sequences of primers are reported in Table 1. Quantitative RT-PCR
sample value was normalized for the expression of β-actin mRNA.
The relative level for each gene was calculated using the 2-ΔΔCt
method [33] and was reported in arbitrary units. In all experiments
each sample was analyzed in triplicate.
2.8. Reverse-Phase Protein Microarray Analysis (RPMA)
RPMAwas carried out as reported byWulfkuhle et al. [34]. Treated
and untreated cells were lysed using the Tissue Protein Extraction Re-
agent (TPER Reagent, Pierce, Rockford, IL) containing 5 M of NaCl
(Sigma-Aldrich), 100 of mM orthovanadate (Sigma-Aldrich), 200
of mM PEFABLOC (AEBSF — Roche), 5 mg/mL of Aprotinin (Sigma-
Aldrich), 1 mg/mL of Pepstatin A (Sigma-Aldrich), 5 mg/mL of
Leupeptin (Sigma-Aldrich). Protein concentration was determined
by Bradford Assay and samples were diluted to 1.0 mg/mL with 2×
Tris-Glycine SDS Sample Buffer (Novex/Invitrogen) plus 5.0% β-
mercaptoethanol (Sigma-Aldrich). The lysates were spotted onto
nitrocellulose-coated glass slides (Whatman, Inc, Sanfort, ME, USA)
using a 2470 Arrayer (Aushon BioSystems, Burlington, MA, USA)rward primer Reverse primer
ATGCCAACACAGTGCTGTC GCTCAGGAGGAGCAATGATC
TCTCAGACCACTTCCTCAG GGCAGTCCTCAATTCTCACC
GAGCCACCGATTACACGTC TGATCCACACCACTGTCCCC
ACTGACCGGAAGTGAGGAG CCAAGGTTGTGAGGTTAGGC
CTGCTGGGAGTGTGGTGGC GGCAGGCACGGAGGCAGTC
CTGTCCATGTATGTGTTCC AAGGCGTGCACCAACACACC
s of the forward and reverse primers are presented. Abbreviation: APC: adenomatosis
Fig. 1. ANP affects cell proliferation and DNA synthesis in DHD/K12/Trb cells. a) Cells were treated with 1 μMANP and mitotic index was evaluated for a period of 3 h to 24 h; results
are given as percentage of cells in mitosis; **, Pb0.01. b) Cell morphology was analyzed after 24 h of ANP treatment by phase contrast microscopy. Bar: 50 μm. c) Cell proliferation
was evaluated after immunoﬂuorescent staining of Ki67 (green hue, panel on the left); nuclei were stained with propidium iodide (PI — red hue) and the merged images were
obtained; results are given as percentage of cells exhibiting nuclear Ki67 positivity (bar graph on the right). Bar: 75 μm; **, Pb0.01; ***, Pb0.001. (d) Cell proliferation by BrdU in-
corporation assay and cytoﬂuorimetric analysis: in each panel, the percentage of cells in S phase is also reported.
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5-point dilution curves in order to assure that the linear detection
range was encompassed for the chosen antibody concentration. Ly-
sates from i) pervanadate-treated or -untreated human cervical can-
cer Hela cells, and ii) calyculin or etoposide-treated and -untreated
human immortalized T-cells Jurkat, were used as high to low internal
controls for antibody staining speciﬁcity. These controls were spot-
ted onto each array along with the experimental samples. Slides
were desiccated and stored at −20 °C until staining. Blocked arrays
were stained with antibodies on an automated slide strainer (Dako
Cytomation, Carpinteria, CA, USA) using the Catalyzed Signal Ampli-
ﬁcation System kit according to manufacturer's recommendation
(CSA; Dako Cytomation). The staining was completed using the LI-
COR Streptavidin-conjugated IRDye680 ﬂuorophore (LI-COR). Anti-
bodies used for the staining were previously validated by Western
blot analysis and were considered eligible for immunostaining
when showed a single band matched to the proper molecular
weight. Stained slides were scanned individually on a UMAX Power-
Look III scanner (UMAX, Dallas, TX, USA) at 600 dpi (dots per inch)
and were saved as TIFF format in Photoshop 6.0 (Adobe, San Jose,
CA, USA). Images were analyzed with an array analysis software
designed for protein microarray analysis, version 2.X00 (Vigene
Tech, North Billerica, MA, USA). The software allows to perform
spot ﬁnding, local background subtraction, replicate averaging,
and total protein normalization, producing a single value for
each sample at each endpoint. RPMA technology was used to analyze
the activated (phosphorylated) state of pAktT308, pERK1/2T202/Y204,
p-p38MAPKinaseT180/Y182 using the antibodies presented in Supple-
mentary Table 1.2.9. Statistical analysis
Statistical analysis was conducted using the two-tailed Student's
t test and a P value threshold of b0.05. All data were presented as
mean±SD.3. Results
3.1. Effect of ANP on cell proliferation and DNA synthesis in DHD/K12/Trb
cells
ANP exerts an anti-proliferative effect on rat DHD/K12/Trb colon
adenocarcinoma cells, similarly to that previously reported for several
human tumor cells [14–19]. In fact, 1 μM ANP signiﬁcantly decreased
cell proliferation, as demonstrated by: i) the decrease of the mitotic
index (Fig. 1a); ii) the reduced percentage of cells exhibiting nuclear
positivity for Ki67 (Fig. 1c); iii) the inhibition of DNA synthesis
recorded by BrdU incorporation assay (Fig.1d). The anti-proliferative
effect was already observed after 3 h of treatment. This suggests
that the effect of ANP starts immediately after its addition to cell cul-
ture medium. Moreover, after 24 h ANP addition, DHD/K12/Trb cells
showed marked morphological modiﬁcations compared to untreated
controls. Speciﬁcally, cells grew in a more ﬂat shape and in thin
monolayer, with a regular polygonal morphology, resembling to dif-
ferentiated epithelial cells (Fig. 1b).Fig. 2. ANP modiﬁes the intracellular pH of DHD/K12/Trb cells. a) Fluorescence measureme
probe, as described in Materials and methods. The pH variations were monitored during the
crease or decrease in ﬂuorescence intensity, respectively, in the regions of interest (ROIs);
each time point, from all ROIs analyzed in three separate experiments. The effect of ANP (r
(Ctr, gray line) consisted in cells after addition of culture medium alone. b) Representative
and 240 s after ANP, EIPA and Wnt1a addition to cell culture medium; arrowheads point to
Green DND-189 probe, showing that 1 h pre-treatment with 1 μM EIPA is able to prevent th3.2. Induction of intracellular acidiﬁcation by ANP treatment
Given the crucial role played by the intracellular pH in affecting
cell proliferation, we determined the intracellular pH modiﬁcations
in DHD/K12/Trb cells induced by ANP immediately after its addition
to cell culture medium. Intracellular pH was monitored by CLSM dur-
ing the ﬁrst 240 s of ANP treatment, using the LysoSensor Green DND-
189 probe, as previously described [31]. This probe exhibits a pH-
dependent increase in ﬂuorescence intensity upon acidiﬁcation. The
effect of ANP was compared to that of EIPA, used as positive control
of NHE-1-mediated intracellular acidiﬁcation. Similarly to ANP, EIPA
was found to be able to inhibit proliferation of DHD/K12/Trb cell
(Supplementary Fig. 2b). Moreover, in order to verify whether the
speciﬁc activation of the Wnt/β-catenin signaling could inﬂuence
the cellular pH, we also analyzed the effect of Wnt1a, one of the Friz-
zled ligands that trigger the Wnt pathway and β-catenin stabilization
[35,36]. ANP addition to cell culture medium resulted in a prompt in-
crease of intracellular acidity, more rapid and higher than that one
recorded with EIPA treatment (Fig. 2a and Supplementary Video 1
and Supplementary Video 2). The acidiﬁcation-dependent increase
of LysoSensor ﬂuorescence was observed both in cytosol and acidic
organelles (Fig. 2b). Pre-treatment with EIPA, aimed to block NHE-1
activity, was able to prevent the ANP-induced intracellular acidiﬁca-
tion (Fig. 2c). This demonstrates that the effect of ANP on intracellular
pH of DHD/K12/Trb cells is mediated by the Sodium/Proton
Exchanger-1, as previously shown for EpG2 hepatoblastoma cells
[28]. Moreover, WB analysis revealed that both ANP and EIPA modi-
ﬁed the levels of NHE-1 expression in a similar manner, with a signif-
icant decrease after 24 h treatment (Supplementary Fig. 3).
Conversely, we observed that after the addition of the Wnt signal-
ing activator Wnt1a to cell culture medium, the intracellular acidity
dropped quite instantaneously (Fig. 2a and Supplementary Video 3),
as revealed by the loss of the LysoSensor ﬂuorescent signal from the
cytosol and acidic organelles (Fig. 2b).
3.3. Effect of ANP on β-catenin intracellular distribution and degradation
CLSM observation (Fig. 3a) and WB analysis of cell fraction ex-
tracts (Fig. 3b) showed that ANP induced a redistribution of β-
catenin from nuclear and cytoplasmic compartments to cell–cell junc-
tion sites, between 4 h and 6 h of treatment. In particular, after 6 h
treatment, densitometric analysis revealed an increase in the ratio
membranous βcat
cytosolic=nuclear βcat
of about 5.2-fold higher in ANP treated cells
than the untreated control. This indicates that ANP induces an in-
crease in the expression of this onco-protein at the cell membrane
with a concomitant decrease of its expression in the nuclear and cyto-
solic compartments. β-catenin intracellular redistribution was ac-
companied by a decrease in the expression levels of total β-catenin,
as revealed by WB and densitometric analyses of whole cell lysates
(Fig. 3c, bar graph on the left). Speciﬁcally, the time-related modiﬁca-
tions of β-catenin expression, evaluated by calculating the ratio of
OD atT2
OD atT1
– where T1and T2 refer to subsequent times of treatment –
were more relevant between 4 h and 6 h of ANP treatment, as com-
pared to the untreated control (Fig. 3c, bar graph on the right). Atnts of intracellular pH was performed by CLSM using the LysoSensor Green DND-189
ﬁrst 240 s of treatment; intracellular acidiﬁcation or alkalinization are recorded as in-
for each sample, the ﬁnal curve represents the mean ﬂuorescence intensity values in
ed line) was compared to that of EIPA (cyan line) and of Wnt1a (orange line); control
images by CLSM of LysoSensor Green DND-189 staining in DHD/K12/Trb cells before
acidic organelles. c) Fluorescence measurements of the intracellular pH by LysoSensor
e ANP-induced increase of intracellular acidity (orange line).
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Ser33/Ser37/Thr41 (Fig. 3d), one of the molecular event upstream the
β-catenin ubiquitination and degradation at the proteosome, has
been recorded. Taken together, these results indicate that ANP triggers
degradation of stabilized β-catenin. Interestingly, a redistribution of
β-catenin at the cell membrane as well as an increase in β-catenin
phosphorylation was also recorded in EIPA treated cells (Fig. 3c, d
and Supplementary Fig. 2a). This suggests that these effects might
also be related to the NHE-1-mediated intracellular acidiﬁcation.
The redistribution of β-catenin from the nuclear space to cell–cell
junctions, as well as the decrease in the number of viable cells as com-
pared to that recorded for DHD/K12/trb cells, have been also observed
in the human colorectal cancer cells SW620 after ANP treatment.
SW620 cells exhibit the constitutive activation of the Wnt/β-catenin
pathway, characteristic of colorectal cancer (Supplementary Fig. 4).
On the contrary ANP treatment did not signiﬁcantly inﬂuence intra-
cellular β-catenin distribution in the human breast cancer cell line
MDA-MB-231, and affected weakly the viability of these cells (Sup-
plementary Fig. 4b). MDA-MB-231 cells do not exhibit the constitu-
tive Tcf-β-catenin signaling activity, as reported by Van de Wetering
et al. [37] and this has been conﬁrmed by the absence of nuclear β-
catenin (Supplementary Fig. 4a). These results indicate that the
anti-proliferative capacity of ANP, induced through reversion of β-
catenin stabilization, is not restricted to the DHD/K12/trb rat colorec-
tal cancer cell line and is more relevant in cells exhibiting the consti-
tutive activation of the Wnt/β-catenin pathway.
3.4. Effect of ANP on E-cadherin expression and intracellular distribution
In DHD/K12/Trb cells, E-cadherin, one of the most important ad-
hesion molecule constituting the cell–cell junctions, is expressed at
very low level (Fig. 4a, left panel), as it frequently occurs in many ad-
vanced epithelial cancers [38]. Concomitantly with the intracellular
redistribution and degradation described for β-catenin, in ANP and,
at lesser extent, in EIPA treated cells, an increase of the E-cadherin ex-
pression and distribution at the cell membrane was recorded. This
was particularly evident between 6 h and 24 h of treatment, as dem-
onstrated by the increment of the ratio
membranous Ecad
cytosolic=nuclear Ecad
from
values≤1 (mainly expressed in the cytosol, similarly to the untreated
control), to values >1, indicative of an increased expression of
E-cadherin at the cell membrane (Fig. 4a, b and Supplementary
Fig. 2a). This suggests that the NHE-1-mediated intracellular acidiﬁ-
cation might also be able to restore cell–cell junction integrity, usual-
ly compromised during cancer progression and resulting in loss of cell
adhesion and increased cell proliferation [39]. The restoration of cell–
cell junction integrity and function as well as the increased expres-
sion of the epithelial differentiation markers E-cadherin might also
be suggestive of tumor phenotype reversion.
3.5. Effect of ANP on the recruitment of β-catenin into the cytoplasmic
“destruction complex”
The effect of ANP on the intracellular distribution of APC and GSK-
3β, two criticalmolecules having a role in β-catenin degradation at the
destruction complex, has also been analyzed. CLSM analysis on β-
catenin/APC double-stained cells (Fig. 5a), showed that the decrease
of stabilized β-catenin in the cytosolic and nuclear compartments
was preceded by an early translocation of the onco-suppressor APC
to the nucleus, occurring between 1 h and 3 h treatment. The increase
of β-catenin/APC colocalization was mainly located at the nuclear
level after 3 h and shifted to the cytoplasm between 3 h and 5 h. This
strongly suggests that APC, through its described shuttling function
[40], could participate to the β-catenin nuclear export toward the cy-
toplasmic destruction complex.Moreover, between 3 h and 5 h of ANPtreatment, GSK-3β – the kinase mediator of β-catenin proteosomic
degradation – colocalized with β-catenin mainly in the cytoplasm,
with a higher colocalization rate (CR) compared to the untreated con-
trol (Fig. 5b). The augmented colocalization of β-catenin with both
APC and GSK-3β in the cytoplasm, suggests that ANP induces β-
catenin recruitment into the destruction complex. QPCR analysis
revealed that, after 4 h, the transcription of APC and GSK-3β genes
was signiﬁcantly up-regulated by the ANP treatment (2.3-fold of in-
duction vs untreated control), which was consistent with their onco-
suppressive function at the destruction complex (Fig. 5c). Similarly,
EIPA treatment induced an up-regulation of APC gene transcription
(2-fold of induction vs untreated control), but at a lower extent as
compared to ANP. However, in EIPA treated cells, no signiﬁcant mod-
iﬁcation was recorded for GSK transcripts at the analyzed time points
(till 10 h treatment).
3.6. Inﬂuences of ANP treatment on the transcription of the Wnt/β-
catenin pathway target genes
We also evaluated the ability of ANP to affect the transcription of
c-Myc and Cyclin D-1, two of the main target genes regulated by the
TCF-β-catenin complex, which up-regulation drives cell proliferation.
As showed by QPCR analysis, ANP was able to induce a signiﬁcant
down-regulation of c-Myc and Cyclin D-1 gene transcription between
2 h and 6 h of treatment (Fig. 5d). This is consistent with the early ef-
fect on DHD/K12/Trb cell proliferation recorded between 3 h and 6 h
treatment (Fig. 1). Moreover, E-cadherin gene expression – which is
usually down-regulated by the Wnt/β-catenin signaling cascade
[41,42] – was signiﬁcantly up-regulated between 6 h and 10 h
ANP treatment (Fig. 5d). The transcription of c-Myc, Cyclin D-1 and
E-cadherin genes was not signiﬁcantly inﬂuenced, at the examined
time points, by EIPA treatment.
3.7. Involvement of a Frizzled receptor-mediated mechanism in the ANP-
induced effect on the intracellular pH and the Wnt/β-catenin signaling
cascade
DHD/K12/trb cells were subjected to double immuno-staining for
the Frizzled receptor and ANP, after 30 min, 1 h and 2 h of treatment
with the natriuretic hormone. Confocal microscopic observation
showed that the Frizzled- and ANP-deriving immunoﬂuorescent sig-
nals colocalized on cell membrane already 30 min after the ANP addi-
tion to culture medium (Fig. 6a). Moreover, pre-treatment with the
Frizzled ligand Wnt1a, aimed to saturate the speciﬁc receptor, was
able to prevent the effects triggered by ANP. Speciﬁcally, 1 h pre-
exposure of cells to 100 μg/ml Wnt1a inhibited the ANP-induced in-
tracellular acidiﬁcation (Fig. 6b) and the β-catenin redistribution at
the cell membrane, leading to increased β-catenin stabilization as a
consequence of the speciﬁc activation of Wnt signaling (Fig. 6c). In
addition, pre-treatment with Wnt1a signiﬁcantly prevented the in-
hibitory effect exerted by ANP on cell proliferation (Fig. 6d). This sug-
gests an involvement of a Frizzled receptor-mediated mechanism in
the ANP anti-proliferative activity. Vice versa, 1 h pre-exposure of
cells to ANP prevented the increase of the β-catenin stabilization trig-
gered by Wnt1a. This leads to the β-catenin redistribution at the cell
membrane and to the decrease of cell proliferation, as effects of the
ANP treatment (Fig. 6c, d). Conversely, 1 h pre-exposure of cells to
EIPA did not affect the Wnt1a-induced β-catenin stabilization, but in-
duced an increase of the β-catenin distribution at the cell membrane
(Fig. 6c), without any relevant effect on cell proliferation (Fig. 6d).
3.8. Negative regulation of ANP on the Akt-mediated inactivation of GSK-
3β via Serina 9 phosphorylation
Finally, we evaluated if the ANP-induced inhibition of Wnt signal-
ing could be correlated to a decrease of the levels of pGSK-3βSer9, the
Fig. 3. ANP modiﬁes β-catenin intracellular distribution and stimulates β-catenin degradation. a) Representative images by CLSM of the intracellular distribution of β-catenin in
control and ANP treated cells after 6 h of culture. Bar: 10 μm. b) WB of β-catenin expression in the membrane and soluble (Cytosol/nucleus) fractions after 4 h, 6 h and 24 h of
ANP treatment, compared to the untreated control; data from densitometric analysis are also reported as ratio of
OD Membrane fraction
OD CyþNufraction (bar graph on the right). c) WB of β-catenin
expression in total cell lysates from ANP treated cells, compared to that from untreated control and EIPA treated samples. Results from the densitometric analysis of β-catenin levels
(bar graph on the left), normalized to β-actin, are also reported as ratio of
OD atT2
OD atT1
, where T1and T2 refer to subsequent times of treatment (bar graph on the right): values b1 are
indicative of a time-correlated decrease of β-catenin expression. d) WB of pβ-cateninSer33/Ser37/Thr41 expression in total cell lysates from ANP treated cells, compared to untreated
control and EIPA treated samples; densitometric analysis in the bar graph on the right reports ratio of
phospho β catenin
total β catenin
. **, Pb0.01; ***, Pb0.001.
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Fig. 4. ANP increases E-cadherin expression and distribution at cell membrane. a) Representative images by CLSM of the intracellular distribution of E-cadherin in control and ANP
treated cells after 24 h of culture. Bar: 50 μm. b)WB of E-cadherin expression in membrane and soluble (Cytosol/nucleus) fractions after 6 h and 24 h of ANP treatment, compared to
that from untreated control; data from densitometric analysis are also reported as ratio of
OD Membrane fraction
OD CyþNufraction (bar graph on the right); values >1are indicative of an increased
expression of E-cadherin at the cell membrane c) WB of E-cadherin expression in total cell lysates from ANP treated cells compared to that from untreated control and EIPA treated
samples; results from the densitometric analysis of total E-cadherin levels (bar graph on the left) were normalized to β-actin, used as loading control. * Pb0.05; ** Pb0.01;
***Pb0.001.
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ANP was able to signiﬁcantly reduce the expression levels of pGSK-
3βSer9 (a decrease of about 2.5-fold ), as compared to untreated con-
trol, in which an increase of about 3.2-fold was conversely recordedFig. 5. Recruitment of β-catenin into the cytoplasmic “destruction complex” induced by ANP
β-catenin/APC double-stained cells after 3 h and 5 h ANP treatment; the white pixels on the
calization rates (CR), calculated using the LasAF software as described in Materials and meth
cells after 3 h and 5 h ANP treatment; colocalization areas of β-catenin and GSK-3β are mar
the transcription levels of APC and GSK (c), cMyc, Cyclin-D1 and E-cadherin (d) in untreated
ment. Results represent the mean±SD of two independent experiments, using independen
induction of gene expression as compared with the mRNA expression in untreated cells at 1
ing untreated and treated cells in each time point. * Pb0.05; ** Pb0.01; ***Pb0.001.(Fig. 7a). At the early time points examined, a moderate effect on
pGSK-3βSer9 levels was also evidenced after EIPA treatment, that
was able to counteract the 3.2-fold increase observed in the untreated
control. The dual function of Akt in both inactivating phosphorylation, and effect on the transcription of the Wnt/β-catenin pathway target genes. a) CLSM on
merged images mark the areas in which β-catenin and APC colocalize; the mean colo-
ods (CR ¼ Colocalization Area
Area Foreground
), are also reported. b) β-catenin/GSK-3β double-stained
ked by the white pixels; the mean CRs are also reported. c, d) Real time PCR analysis of
controls, and in ANP- and EIPA-treated cells, at times ranging from 1 h to 10 h of treat-
t cell cultures in each experimental setting. The values reported are the relative fold-
h of culture, expressed as arbitrary units; statistical signiﬁcance was obtained compar-
Fig. 6. ANP affects theWnt/β-catenin pathway through a Frizzled receptor-mediated mechanism. a) CLSM on cells double-stained for Frizzled receptor (green hue) and ANP (red hue), after
30 min, 1 h and 2 h ANP treatment; arrows point to colocalization of the two ﬂuorescent signals (yellow hue) on cell membrane. Bar: 5 μm. b) Fluorescencemeasurements of the intracellular
pH by LysoSensor Green DND-189 probe, performed as described in Materials and methods, showing that 1 h pre-treatment with Wnt1a was able to prevent the ANP-induced increase in
intracellular acidity (orange line). c) CLSM ofβ-catenin intracellular distribution in DHD/K12/Trb cells, in a competition experiment for the binding to the Frizzled receptor. (c1) untreated con-
trol; (c2) 6 h treatment with 1 μM ANP; (c3) 1 h pre-exposure to 100 μg/ml Wnt1a followed by 5 h ANP treatment; (c4) 6 h treatment with 100 μg/ml Wnt1a; (c5) 1 h pre-exposure to ANP
followed by 5 hWnt1a treatment; (c6) 1 h pre-exposure to 1 μM EIPA followed by 5 hWnt1a treatment. Bar: 75 μm. d) Analysis of cell proliferation, by Ki67 immunoﬂuorescent staining, on
samples from a competition experiment for the binding to the Frizzled receptor; results are given as percentage of cells exhibiting nuclear Ki67 positivity. * Pb0.05; ** Pb0.01; ***Pb0.001.
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Ser648 [45], prompted us to evaluate if a reduction of Akt activity
might be a common mechanism underlying the decrease of both
pGSK-3βSer9 and NHE-1 activity triggered by ANP. To this purpose,
measurements of the activation (phosphorylation state) of Akt,
ERK1/2, and p38MAPKinase were performed by Reverse-Phase Pro-
tein Microarray Analysis (RPMA). These three kinases are known to
mediate the activation of NHE-1 by phosphorylation at different ami-
noacidic sites [45–47]. The expression levels of the phosphorylated
forms pAktT308, pERKT202 and p-p38MAPKT180/Y182 were analyzed.
RPMA of total cell lysates revealed that, between 2 h and 24 h treat-
ment, ANP and EIPA affected with a different timing the expression
of the active forms of these three kinases (Fig. 7b, left). Speciﬁcally,
ANP decreased of about 2-fold the levels of pAktT308 between 2 h
and 4 h treatment (Fig. 7b, right). This was consistent with the de-
crease of pGSK-3βSer9 recorded between 4 h and 6 h. On the other
hand, ERK 1/2 and p38MAPK resulted not affected (at 2 h and 4 h)
or increased (at 6 h and 24 h) by ANP treatment. Conversely, EIPA
had an early effect on the phosphorylation state of all the three en-
zymes examined. In particular EIPA treatment primarily induced the
inactivation of ERK 1/2 and p38MAPK, which phosphorylation levels
manly decreased after 4 h of treatment (Fig. 7b, left). A signiﬁcant re-
duction of the Akt activation, with a 2-fold drop in the levels of
pAktT308, was recorded later, between 6 h and 24 h (Fig. 7b, right).
4. Discussion
In this study, we aimed to clarify the molecular mechanism under-
lying the anti-proliferative effect of ANP, which has been extensively
described in several human tumor cells [14–19].Our results show a
connection between the intracellular pH and the Wnt signalingFig. 7. ANP reduces the Akt-mediated inactivation of GSK-3β via Ser9 phosphorylation. a) W
untreated control and EIPA treated samples; results from the densitometric analysis of total
control; **, Pb0.01; ***, Pb0.001. b) Measurements of the activation (phosphorylation state
Analysis (RPMA): the expression levels of the phosphorylated forms pAktT308, pERKT202 a
phospho-proteins (horizontal axis) in total cell lysates after 2 h, 4 h, 6 h and 24 h ANP tre
axis); higher levels of protein phosphorylation are indicated in red on the heatmap and lo
pAktT308 stained array, normalized to the total proteins, is also shown (right panel); * Pb0pathway in cancer cells, two crucial processes for solid tumor surviv-
al. Speciﬁcally, we demonstrate for the ﬁrst time that the inhibition of
tumor cell proliferation by ANP is mediated by a concomitant effect
on the intracellular acidity and the Wnt/β-catenin signaling. Con-
versely, we observed that Wnt1a, that triggers the Wnt pathway
and β-catenin stabilization, is able to inﬂuence pH homeostasis in
the opposite way, causing intracellular alkalinization. This ﬁnding
supports the hypothesis that some crucial molecular events are
shared by the Wnt signaling activation (or inactivation) and the pH
regulation. At present, the mechanism through which ANP inﬂuences
the intracellular pH is unknown; however, it has been reported that
the cationic form of EIPA exerts the inhibitory effect on NHE-1 by a di-
rect interaction with NHE-1 external Na+ binding site [48]. Based on
our results, the comparative analysis of ANP and EIPA treated cells in-
dicates that both molecules act on the NHE-1-mediated intracellular
acidiﬁcation and the Wnt/β-catenin signaling cascade, but with a dif-
ferent timing and through distinct triggering mechanisms. Particular-
ly, ANP operates earlier and at the same time affects the intracellular
pH and theWnt signaling. Thus, we hypothesize that ANPmight exert
an inhibitory effect on the Wnt signaling through a Frizzled receptor-
mediated mechanism relying on a Wnt receptor/ANP direct interac-
tion. This could be plausible, given the presence, in the extracellular
region of the enzyme Corin, of Frizzled domains essential for pro-
ANP binding and processing [11]. Furthermore, our hypothesis is
strongly supported by the following observations: i) the colocaliza-
tion of ANP and the Frizzled receptor on the surface of treated cells
(as shown in Fig. 6a); ii) the inhibition of the ANP-induced decrease
in the intracellular pH through pre-treatment of the Frizzled ligand
Wnt1a (as shown in Fig. 6b); and iii) the ability of ANP and Wnt1a
in competing and displacing each other from the binding to the Friz-
zled receptor (as shown in Fig. 6c).B of pGSK-3βSer9 expression after 4 h and 6 h of ANP treatment, compared to that from
pGSK-3βSer9 levels (bar graph on the left) were normalized to β-actin, used as loading
) of Akt, ERK1/2, and p38MAPKinase performed by Reverse-Phase Protein Microarray
nd p-p38MAPKT180/Y182 were analyzed. Left panel: heatmap of the relative levels of
atment, compared to that from untreated control and EIPA treated samples (vertical
west relative levels in green. Bar graph of the relative intensity values from the anti-
.05; ** Pb0.01.
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lization is well known [43]. Conversely, in the past it has been sug-
gested that Akt could not be directly involved in Wnt signaling
[49,50]. More recently, it has been demonstrated that the Wnt signal-
ing stimulates Akt and that the activated Akt, working in association
with Dishevelled (DSH), enhances the phosphorylation of GSK-3β in
the Axin complex [44].
In this study, we demonstrate that ANP induces a prompt decrease
of pAktT308 – the active form of this enzyme – resulting in a reduction
of the Akt-mediated inactivation of GSK-3β via Ser9 phosphorylation.
The dual function of Akt in both inactivating phosphorylation of GSK-
3β at Ser9 [44] and activating phosphorylation of NHE-1 at Ser648 [45]
suggests that Akt reduced activity could be a common molecular
event underlying the ANP-induced inhibition of both Wnt/β-catenin
signaling cascade and NHE-1 activity. Moreover, the moderate effectFig. 8. Proposed model for the mechanism of ANP action illustrating a possible cross-talk bet
naling cascade. APC, adenomatous polyposis coli; β-cat, β-catenin; CBP, CREB-binding protei
glycogen synthase kinase; LRP, LDL receptor-related protein; NHE, Sodium/Proton Exchangon pGSK-3βSer9 levels observed after EIPA treatment as well as the
2-fold drop in the levels of Akt phosphorylated form (recorded be-
tween 6 h and 24 h) indicates that the speciﬁc inhibition of NHE-1 ac-
tivity might affect the Akt activity and the Akt-mediated inactivation
of GSK-3β. Hence, taken together these observations let us strongly
sustain the hypothesis that Akt activity could be a relevant molecular
event linking the NHE-1-regulated intracellular pH and Wnt/β-catenin
signaling in cancer cells. This also reinforces the assumption of a direct
involvement of Akt in the Wnt signaling.
Furthermore, we propose a mechanism for ANP action illustrating
a possible cross-talk between the NHE-1-dependent intracellular al-
kalinization of tumor cells and the Wnt signaling cascade (Fig. 8).
As it is known, in non-transformed cells, β-catenin exists in a
cadherin-bound form that regulates cell–cell adhesion. The β-
catenin excess not segregated by E-cadherin on the cell membraneween the NHE-1-dependent intracellular alkalinization of tumor cells and the Wnt sig-
n; CK, casein kinase; DKK, Dickkopf; DSH, Dishevelled; GBP, GSK3-binding protein; GSK,
er; P, phosphorylation; TCF, T-cell factor.
1017A. Seraﬁno et al. / Biochimica et Biophysica Acta 1822 (2012) 1004–1018is rapidly phosphorylated by GSK-3β at the destruction complex and
is subsequently degraded by the ubiquitin-proteosome pathway
[5–8]. In our proposed model, Wnt signaling causes a DSH-mediated
phospho-activation of Akt that concomitantly might inactivate GSK-
3β by phosphorylation at Ser9 and activate NHE-1 by phosphorylation
at Ser648, leading to β-catenin stabilization and intracellular alkalini-
zation, respectively (Fig. 8, step 1). Both phenomena result in in-
creased tumor cell proliferation, invasion, and metastatization,
as well as in decreased chemosensitivity. ANP, possibly acting as a
Frizzled ligand that antagonizes the Wnt signaling, reduces the
DSH-mediated Akt activity (Fig. 8, step 2). This causes two concomi-
tant effects: i) the recovery of the GSK-3β activity at the “destruction
complex,” resulting in an increase of β-catenin degradation; ii) the
decrease of active NHE-1 and a consequent intracellular acidiﬁcation.
Both phenomena ultimately inhibit cell proliferation and motility,
and increase chemosensitivity. Our preliminary data indicated that
ANP is also able to reverse the resistance to doxorubicin of a multi-
drug resistant variant of MCF7 breast cancer cells (MCF7/dx). This
strengthens our proposed model of ANP action. On the other hand,
EIPA – that inhibits NHE-1 activity through a direct interaction with
the pH regulator – reduces Akt activity and consequently decreases
GSK-3β inactivation. This ultimately results in an effect on the Wnt/
β-catenin signaling cascade (Fig. 8, step 3). The differences observed
between ANP and EIPA treatments might be possibly due to the fact
that ANP acts upstream and EIPA downstream the Frizzled-
mediated activation of the Wnt signaling.
In conclusion, for the ﬁrst time, we show evidence for a molecular
connection between theWnt signaling cascade and the intracellular al-
kalinization in tumor cells. This provides innovative information about
the causal mechanisms that make the pH of the cancerous microenvi-
ronment more acidic than that one of the normal tissues. These excit-
ing results encourage further studies aiming to better clarify the
molecular events by which the expression and activity of pH regula-
tors, particularly NHE-1, inﬂuence tumor progression and malignancy.
Moreover, we would emphasize the validity of ANP and similar mole-
cules that function as NHE-1 inhibitors and/or as Frizzled ligands an-
tagonizing the Wnt signaling. They might have the peculiarity of
simultaneously targeting the acidic tumor microenvironment and the
Wnt signaling. Thus, these molecules might be considered as the
“magic bullets” against cancer, opening up a new perspective for the
development of novel antitumor therapeutic strategies.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbadis.2012.02.016.
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